down arrow

Dr Lal Pathlabs

  • Market Cap: Large Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE600L01024
  • NSEID: LALPATHLAB
  • BSEID: 539524
INR
2,675.45
8.5 (0.32%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 87.92 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1000163,
    "name": "Dr Lal Pathlabs",
    "stock_name": "Dr Lal Pathlabs",
    "full_name": "Dr Lal Pathlabs Ltd",
    "name_url": "stocks-analysis/dr-lal-pathlabs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,675.45",
    "chg": 8.5,
    "chgp": "0.32%",
    "dir": 1,
    "prev_price": "2,666.95",
    "mcapval": "22,364.55 Cr",
    "mcap": "Large Cap",
    "scripcode": 539524,
    "symbol": "LALPATHLAB",
    "ind_name": "Hospital & Healthcare Services",
    "ind_code": 94,
    "isin": "INE600L01024",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "22:55 PM",
    "bse_nse_vol": "87.92 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-lal-pathlabs-1000163-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Dr Lal Pathlabs Shows Trend Reversal Amid Mixed Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-gains-3-14-amid-positive-market-conditions-on-april-2-2025-1678468",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/DrLalPathlabs_priceRelatedfactors_877269.png",
        "date": "2025-04-02 14:35:22",
        "description": "Dr Lal Pathlabs experienced a notable performance on April 2, 2025, reversing a two-day decline. The stock reached an intraday high and is currently positioned above its short-term moving averages, while lagging behind longer-term averages. Year-to-date, it has faced challenges compared to the broader market."
      },
      {
        "title": "Dr Lal Pathlabs Faces Decline Amid Broader Market Downturn and Underperformance Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-stock-declines-3-15-underperforms-market-and-sector-indices-1662312",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/DrLalPathlabs_priceRelatedfactors_854025.png",
        "date": "2025-04-01 12:05:21",
        "description": "Dr Lal Pathlabs has faced a significant decline amid a broader market downturn, underperforming its sector and experiencing consecutive losses. The stock is currently trading below key moving averages, indicating a bearish trend. Despite a yearly increase, its year-to-date performance and three-year outlook remain concerning compared to the Sensex."
      },
      {
        "title": "Dr. Lal Pathlabs Faces Mixed Technical Trends Amidst Strong Long-Term Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-volatility-1598461",
        "imagepath": "",
        "date": "2025-03-26 08:04:14",
        "description": "Dr. Lal Pathlabs, a prominent player in the Hospital & Healthcare Services sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 2499.15, slightly down from the previous close of 2505.70. Over the past year, the company has demonstrated a return of 17.43%, significantly outperforming the Sensex, which recorded a return of 7.12% in the same period.\n\nIn terms of technical indicators, the weekly MACD and Bollinger Bands suggest a bearish sentiment, while the monthly indicators show a mildly bearish trend. The KST presents a mixed picture, with a bullish stance on a monthly basis, contrasting with the bearish weekly outlook. The Dow Theory indicates a mildly bullish trend on a weekly basis, although it shifts to mildly bearish on a monthly scale.\n\nThe stock's performance over various time frames reveals a complex picture. While it has face..."
      },
      {
        "title": "Dr Lal Pathlabs Navigates Mixed Performance Amid Sector Outperformance and Market Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-gains-3-02-amid-positive-market-trend-on-march-10-2025-1515425",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/DrLalPathlabs_priceRelatedfactors_638731.png",
        "date": "2025-03-10 11:35:23",
        "description": "Dr Lal Pathlabs experienced significant trading activity, outperforming its sector and reaching an intraday high. The stock shows mixed performance across various moving averages and has had a strong week, despite a decline over the past month and year-to-date. It has outperformed the Sensex over the past year."
      },
      {
        "title": "Dr Lal Pathlabs Shows Resilience Amid Mixed Market Trends and Small-Cap Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-stock-rises-3-68-outperforming-sector-amid-broader-market-gains-1219422",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/DrLalPathlabs_priceRelatedfactors_610569.png",
        "date": "2025-03-06 14:05:22",
        "description": "Dr Lal Pathlabs has experienced significant activity, marking its fourth consecutive day of gains and outperforming its sector. The stock's performance shows a mixed trend relative to various moving averages. In the broader market, the Sensex opened higher, with small-cap stocks leading the gains."
      },
      {
        "title": "Dr. Lal Pathlabs Faces Technical Trend Shifts Amid Market Volatility and Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-technical-trend-shifts-from-mildly-bearish-to-bearish-amid-stock-volatility-1213609",
        "imagepath": "",
        "date": "2025-03-06 08:02:37",
        "description": "Dr. Lal Pathlabs, a prominent player in the Hospital & Healthcare Services sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 2,422.15, showing a slight increase from the previous close of 2,388.70. Over the past year, the stock has reached a high of 3,645.00 and a low of 1,943.20, indicating significant volatility.\n\nThe technical summary reveals a bearish sentiment in the weekly MACD and daily moving averages, while the monthly indicators show a mildly bearish trend. The Relative Strength Index (RSI) remains neutral, suggesting a lack of strong momentum in either direction. Additionally, the Bollinger Bands and KST metrics indicate mixed signals, with the KST showing bullish tendencies on a monthly basis.\n\nIn terms of performance, Dr. Lal Pathlabs has experienced varied returns compared to the Sensex. Over the past week, the stock ..."
      },
      {
        "title": "Dr. Lal Pathlabs Faces Technical Trend Challenges Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-mixed-signals-1178716",
        "imagepath": "",
        "date": "2025-03-04 08:01:23",
        "description": "Dr. Lal Pathlabs, a prominent player in the Hospital & Healthcare Services sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 2,349.90, showing a slight increase from the previous close of 2,309.70. Over the past year, the stock has reached a high of 3,645.00 and a low of 1,943.20, indicating significant volatility.\n\nIn terms of technical indicators, the MACD shows a bearish trend on a weekly basis while being mildly bearish on a monthly scale. The Relative Strength Index (RSI) indicates bullish momentum weekly, but no signal is present on a monthly basis. Bollinger Bands and Dow Theory both reflect a mildly bearish stance for the weekly and monthly periods. The KST presents a mixed picture, being bearish weekly but bullish monthly.\n\nWhen comparing the stock's performance to the Sensex, Dr. Lal Pathlabs has faced challenges, particu..."
      },
      {
        "title": "Dr Lal Pathlabs Faces Continued Stock Decline Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-stock-declines-3-11-underperforms-healthcare-sector-by-3-14-1109658",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/DrLalPathlabs_priceRelatedfactors_512832.png",
        "date": "2025-02-25 10:35:20",
        "description": "Dr Lal Pathlabs has faced a significant decline in stock performance, marking three consecutive days of losses and an overall drop of 4.66%. The company has underperformed compared to its sector and is trading below key moving averages, reflecting ongoing challenges in the market."
      },
      {
        "title": "Dr Lal Pathlabs Faces Stock Volatility Amidst Challenging Market Conditions",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-shares-drop-30-73-from-recent-highs-amid-mixed-performance-1109937",
        "imagepath": "",
        "date": "2025-02-25 10:19:49",
        "description": "Dr Lal Pathlabs Ltd, a prominent player in the Hospital & Healthcare Services sector, has experienced significant fluctuations in its stock performance. Currently, the stock is down 30.73% from its recent high, reflecting a challenging market environment. Over the past year, Dr Lal Pathlabs has posted a modest return of 2.36%, slightly outperforming the Sensex, which recorded a 2.12% gain. However, the stock has faced notable declines in shorter time frames, including a 3.17% drop today and an 11.32% decrease over the past month.\n\nDespite a five-year performance increase of 51.68%, the stock's year-to-date performance shows a decline of 16.25%, contrasting with the Sensex's 4.41% drop. The company's price-to-earnings ratio stands at 51.86, slightly above the industry average of 50.19, indicating a relatively high valuation. Dr Lal Pathlabs maintains a strong management efficiency with a return on equity of ..."
      }
    ],
    "total": 133,
    "sid": "1000163",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/dr-lal-pathlabs-1000163"
  },
  "announcements": [
    {
      "caption": "Grant Of Stock Options",
      "datetime": "09-Apr-2025",
      "details": "Disclosure Attached",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "31-Mar-2025",
      "details": "Disclosure attached",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2025",
      "details": "Intimation of Closure of Trading Window",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dr Lal Pathlabs Ltd has declared <strong>60%</strong> dividend, ex-date: 05 Feb 25",
          "dt": "2025-02-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Grant Of Stock Options

09-Apr-2025 | Source : BSE

Disclosure Attached

Announcement under Regulation 30 (LODR)-Change in Directorate

31-Mar-2025 | Source : BSE

Disclosure attached

Closure of Trading Window

25-Mar-2025 | Source : BSE

Intimation of Closure of Trading Window

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Dr Lal Pathlabs Ltd has declared 60% dividend, ex-date: 05 Feb 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available